-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

Benzinga·04/04/2025 14:34:54
Listen to the news
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and lowers the price target from $12 to $8.